[#1999-04] Activity of Edible Mushrooms...

 Activity of Edible Mushrooms Against the Growth of Human T4 Leukemic Cancer Cells, HeLa Cervical Cancer Cells and Plasmodium falciparum Lovy, A(a), Knowles, B(b), Labbe, R, Nolan(c), L(b) a) Institute of Biological Chemistry, Washington State University, b) Department of Environmental Health Sciences, University of Massachusetts, c) Food Science Department, University of Massachusetts Several edible Hymenomycete mushroom species have been screened as possible inhibitors of human T4 leukemic cancer cells, HeLa cervical cancer cells, Plasmodium falciparum (a pyrimethamine...

[#1998-06] Triterpenes from the Spores o...

Triterpenes from the Spores of Ganoderma lucidum and Their Inhibitory Activity against HIV-I Protease Byung-Sun Min, Norio NAKAMURA, Hirotsugu MIYASHIRO, Ki-Whan Bae, and Masao HATTORI   Two new lanostane-type triterpenes, lucidumol A and ganoderic acid β, were isolated from the spores of Reishi ( Ganoderma lucidum ), together with a new natural one and seven that were known. The structures of the new triterpenes were determined as (24S)-24,25-dihydroxylanost-8-ene-3,7-dione and 3β,7β-dihydroxy-11,15-dioxo­lanosta-8,24(E)-dien-26-oic acid, respectively, by...

[#1993-04] Anti-Hypertensive Effect by t...

Anti-Hypertensive Effect by the King of Mushrooms Nanba, H Kobe Women’s College of Pharmacy The fungi which belong to Basidiomycetes have been used as herbal medicines for a long time. It has been found that shiitake (Lentinus edodes) and mannentake or reishi (Ganoderma lucidum) are effective against essential hypertension. The author was quite curious about the hypotensive action of Maitake (Grifola frondosa), another mushrooom belonging to basidiomycetes. In fact, the finding of this activity was a result of studying the antitumor activity of Maitake. In this...

[#1985-06] Reishi Kohda, Hiroshi et al. ...

The Biologically Active Constituents of Ganoderma lucidum (FR..) KARST. Histamine Release-Inhibitory Triterpenes HIROSHI KOHDA,a WAKAKO TOKUMOTO,a KIYOE SAKAMOTO,a MICHIKO FUJII,a YUKO HIRAI,a KAZUO YAMASAKI,*’ a YASUO KOMODA,bHIDEO NAKAMURA,` SHIGEMASA ISHIHARA`and MASARU UCHIDA` Institute of Pharmaceutical Sciences, School of Medicine, Hiroshima University,’1-2-3, Kaszoni, Minami-ku, Hiroshima 734, Japan, Institute for Medical andDental Engineering, Tokyo Medical and Dental University,’ 2-3-10,Surugadai, Kanda, Chiyoda-ku, Tokyo 101, Japan and Research...